Oct 12 (Reuters) - NeoGenomics Inc :NeoGenomics announces preliminary quarter 3 results, financial impacts of hurricanes and summary quarter 4 guidance.NeoGenomics Inc - it expects to report quarter 3 revenue of approximately $63.1 million and adjusted EBITDA of approximately $6.0 million.NeoGenomics Inc - NeoGenomics estimates that hurricanes Harvey and Irma depressed revenue by approximately $1.0 million in quarter 3.NeoGenomics inc - in addition, as a result of divestiture of pathlogic, Q3 revenue will be approximately $1.3 million less than in quarter 2.NeoGenomics Inc - expects consolidated revenue of $65 million - $67 million and adjusted EBITDA of $9 million -10 million in Q4.NeoGenomics-For Q3,expects to record $1.3 million revenue adjustment to reflect change in process for estimating revenue for unbilled tests at quarter-end.Q3 revenue view $65.9 million -- Thomson Reuters I/B/E/S.Q4 revenue view $69.1 million -- Thomson Reuters I/B/E/S.
Oct 3 (Reuters) - Amedisys Inc ::Amedisys Inc says on october 2, 2017, company announced that it will close four florida home health care centers- SEC filing .Amedisys- as a result of restructuring actions, co incurred non-recurring charges of approximately $2.0 million during Q3 of 2017.Amedisys-As a result of restructuring actions, expects to incur additional non-recurring charges in range of $2.0 million to $3.0 million during Q4 of 2017.Amedisys - upon completion of restructure company anticipates an annual improvement in EBITDA in range of $7.0 million to $9.0 million in 2018.
Sept 11 (Reuters) - IHH Healthcare Bhd :Tokushukai-Sofia and Acibadem City Clinic EAD merged on 8 September 2017.Internal reorganisation will not have any effect on earnings of IHH for the financial year ending 31 December 2017.
Aug 31 (Reuters) - Total Face Group Ltd :board to undertake strategic review of operations and capital structure of co.
Aug 30 (Reuters) - Ramsay Health Care Ltd :FY net profit after tax for the period attributable to owners $488.9 million versus $450.3 million .FY revenue and other income $8.71 billion, up 0.2 percent .Expect strong growth in our australian hospital business to continue in fy18.Barring unforeseen circumstances, ramsay is targeting core eps growth of 8% to 10% for FY18.Final proposed dividend 81.5 cents per share.
Aug 10 (Reuters) - Unimat Retirement Community Co Ltd <9707.T>:Says it plans to take over partial restaurant business, manufacturing and sales of coffee beans and operation business of coffee shop from a Tokyo-based firm UNIMAT PRECIOUS.Says it plans to fully acquire UNIMAT PRECIOUS's wholly owned unit Avril de Bergue on Oct. 1, which is engaged in manufacturing and sales of western-style confections.Says it will transfer the business which will be taken over from UNIMAT PRECIOUS to the unit .says acquisition price is 2.71 billion yen .
Aug 8 (Reuters) - BioScrip Inc :BioScrip reports second quarter 2017 financial results.Q2 revenue $218.1 million versus I/B/E/S view $220.2 million.Sees FY 2017 revenue $815 million to $835 million.Qtrly loss per share $0.26.Q2 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S.BioScrip Inc - is reiterating its prior guidance of adjusted ebitda in range of $45.0 million to $55.0 million for full-year 2017..BioScrip Inc - company expects to incur restructuring expenses in a range of $11.0 million to $12.0 million in 2017.FY 2017 revenue view $865.9 million -- Thomson Reuters I/B/E/S.
July 21 (Reuters) - Skyocean International Holdings Ltd <0593.HK>::Unit and Hunan Dreameast Cultural Investment as vendor enters hengyang dreameast project development plans transfer agreement.Hunan Dreameast agreed to sell project plans prepared by Hunan Dreameast in relation to Hengnan Land at consideration of RMB9 million.Jiaxing Dreameast Cultural Investment and zhejiang dreameast cultural entered into Jiashan Dreameast Project Development Plans Transfer Agreement.Pursuant to Jiashan Dreameast Project Development Plans Transfer Agreement, Zhejiang Dreameast agreed to sell project plans for RMB1.5 million.
July 17(Reuters) - Winning Health Technology Group Co Ltd <300253.SZ> ::* Sees H1 FY 2017 net profit to decrease by 77 percent to 80 percent, or to be 85.6 million yuan to 96.7 million yuan.* Says H1 FY 2016 net profit was 423.5 million yuan.* The reasons for the forecast are sustainable development of medical and health information service business and promotion in innovative Internet and health services business as well as increased investment return .